Loading...
Mesalamine
India Pharmaceutical Trade Intelligence
Who Supplies Mesalamine to India from CANADA
India's mesalamine imports from CANADA total $12.6K across 20 shipments from 11 foreign suppliers. GLOBYZ PHARMA leads with $4.2K in import value; the top 5 suppliers together control 84.1% of this origin. Leading Indian buyers include ZYDUS LIFESCIENCES LIMITED. This corridor reflects India's pharmaceutical import demand for mesalamine — a diversified sourcing base with multiple active suppliers from CANADA.
Top foreign suppliers (CANADA) — Ranked by import value
GLOBYZ PHARMA is the leading Mesalamine supplier from CANADA to India, with import value of $4.2K across 5 shipments. The top 5 suppliers — GLOBYZ PHARMA, ESPEE PHARMA CANADA INC, ESPEE PHARMA CANADA INC., TARO PHARMACEUTICALS INC, JAMP PHARMA CORPORATION — collectively account for 84.1% of total import value from this origin.
Top foreign suppliers (CANADA)
Ranked by import value (USD) · Indian Customs (DGFT) data
| # | Supplier | Value (USD) | Shipments | Share |
|---|---|---|---|---|
| 1 | GLOBYZ PHARMA | $4.2K | 5 | 33.4% |
| 2 | ESPEE PHARMA CANADA INC | $2.2K | 3 | 17.6% |
| 3 | ESPEE PHARMA CANADA INC. | $1.9K | 2 | 15.4% |
| 4 | TARO PHARMACEUTICALS INC | $1.2K | 1 | 9.2% |
| 5 | JAMP PHARMA CORPORATION | $1.1K | 2 | 8.5% |
| 6 | NEW LIFE MEDICALS (USA) INC. | $848 | 1 | 6.7% |
| 7 | ADIRAMEDICA INC | $483 | 1 | 3.8% |
| 8 | GLOBYZ BIOPHARMA SERVICES | $322 | 2 | 2.5% |
| 9 | NEWLIFE MEDICALS (USA). INC. | $267 | 1 | 2.1% |
| 10 | Globyz Biopharma Services | $80 | 1 | 0.6% |
| 11 | NewLife Medicals USA Inc | $2 | 1 | 0.0% |
Showing top 11 of 11 foreign suppliers · Indian Customs (DGFT) · TransData Nexus
Top Indian buyers (importing from CANADA)
Ranked by import value (USD)
| # | Buyer | Value (USD) | Shipments | Share |
|---|---|---|---|---|
| 1 | ZYDUS LIFESCIENCES LIMITED | $4.7K | 5 | 37.6% |
| 2 | INDOCO REMEDIES LIMITED | $3.4K | 4 | 27.1% |
| 3 | CLIANTHA RESEARCH LIMITED | $1.4K | 3 | 11.0% |
| 4 | SUN PHARMACEUTICAL INDUSTRIES LIMITED | $1.2K | 1 | 9.2% |
| 5 | CADILA HEALTHCARE LIMITED | $848 | 1 | 6.7% |
| 6 | JAMP INDIA PHARMACEUTICALS PRIVATE LIMITED | $585 | 4 | 4.6% |
| 7 | AXXELENT PHARMA SCIENCE PRIVATE LIMITED | $483 | 1 | 3.8% |
| 8 | AIZANT DRUG RESEARCH SOLUTIONS PRIVATE LIMITED | $2 | 1 | 0.0% |
Import Statistics
- Import Value
- $12.6K
- Shipments
- 20
- Foreign Suppliers
- 11
- Indian Buyers
- 8
- Avg. Shipment
- $631
Other Mesalamine Import Origins
Related Analysis
Frequently Asked Questions — Mesalamine Imports from CANADA
Answers based on Indian Customs (DGFT) import records compiled by TransData Nexus
QWho are the top Mesalamine suppliers from CANADA to India?
The top Mesalamine suppliers from CANADA to India include GLOBYZ PHARMA, ESPEE PHARMA CANADA INC, ESPEE PHARMA CANADA INC.. The leading supplier is GLOBYZ PHARMA with import value of $4.2K USD across 5 shipments. India imported Mesalamine worth $12.6K USD from CANADA in total across 20 shipments.
QHow much Mesalamine does India import from CANADA?
India imported Mesalamine worth $12.6K USD from CANADA across 20 shipments. Data is from Indian Customs (DGFT) records. Values are in USD.
QWho are the main Indian buyers of Mesalamine from CANADA?
The main Indian buyers of Mesalamine sourced from CANADA include ZYDUS LIFESCIENCES LIMITED, INDOCO REMEDIES LIMITED, CLIANTHA RESEARCH LIMITED. The largest buyer is ZYDUS LIFESCIENCES LIMITED with $4.7K in imports across 5 shipments.
QWhat is the total value of Mesalamine imports from CANADA to India?
The total value of Mesalamine imports from CANADA to India is $12.6K USD, across 20 shipments and 11 foreign suppliers. Data source: Indian Customs (DGFT).
Official References & Regulatory Resources
- India Trade Statistics (DGFT)
- Invest India — Pharma Sector
- WCO HS Nomenclature
- Ministry of Commerce — Pharma Exports
- Pharmexcil
Data sourced from Indian Customs (DGFT) records. Verify regulatory and trade status with the agencies above.
Research Methodology & Data Transparency
SS
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Route Identification: CANADA to India pharmaceutical import trade corridor identified from Indian Customs (DGFT) shipping bill records for Mesalamine.
- 2.Supplier/Buyer Matching: 11 foreign suppliers from CANADA and 8 Indian buyers identified using company name normalization across customs records.
- 3.Value Aggregation: Total import value of $12.6K aggregated from 20 verified shipping bill records. All values reported in FOB USD as recorded by Indian Customs.
- 4.Market Share Analysis: Each supplier and buyer contribution calculated as a percentage of total route value. Statistical normalization applied to ensure accurate representation across varying shipment sizes.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
20 Verified Shipments
11 suppliers, 8 buyers tracked
Expert-Reviewed
By pharmaceutical trade specialists